Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by tickle1ston May 23, 2014 4:25pm

222 Views

Post# 22594053

RE:RE:Pigs at the trough are killing this

MWMan,

The reason there is no volume is the market recognizes that Sirona is just a 10 cent share printing machine right now. And will continue to be for what looks like a long time. This cheap paper hurts everyone but the ones getting it...and maybe they get it up the butt too if they do it one...or one million times too many times.

Vancouver stock exchange mentality is the stench this company has aquired. Nobody like that smell except the pigs producing the gas...It started out that way and it looks like Niel agrees with the inflationary/dilution share model by the way the paper is littering the pigs pen. OMHO of course...

too bad really

Bullboard Posts

Eminent acquires promising Nevada gold project